Nores G A, Hanai N, Levery S B, Eaton H L, Salyan E K, Hakomori S
Department of Biochemical Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA 98119.
Carbohydr Res. 1988 Aug 15;179:393-410. doi: 10.1016/0008-6215(88)84135-1.
Various GM3 derivatives which are present in A431 cells have different effects on the activity of the EGF receptor kinase. In order to systematically study these effects, the following GM3 derivatives have been synthesized: de-N-acetyl-GM3 (D1), de-N-acetyl-lyso-GM3 (D2), lyso-GM3 (D3), de-N-acetyl-GM3 with N-acetylsphingosine (D4), and GM3 with N-acetylsphingosine (D3). A crucial step for the preparation of D1 is the use of mild alkaline conditions of hydrolysis under which the N-acetyl group of sialic acid is preferentially hydrolyzed. For the preparation of D3, conditions which allowed preferential N-acetylation of the amino group of the neuraminic acid moiety were devised, i.e., D2 was incorporated in a dipalmitoyl-phosphatidylcholine (dpPC) liposome in which the sphingosine moiety was protected and the amino group of neuraminic acid was N-acetylated with acetate and a water-soluble catalyst, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (DEC). When an aqueous micellar solution of D2 was treated with acetic anhydride and sodium hydrogencarbonate, N-acetylation occurred at the amino groups of both neuraminosyl and sphingosyl residues, yielding D5. The structures of these derivatives were verified by 1H-n.m.r. spectroscopy and mass spectrometry.
A431细胞中存在的各种GM3衍生物对表皮生长因子(EGF)受体激酶的活性有不同影响。为了系统地研究这些影响,已合成了以下GM3衍生物:去-N-乙酰基-GM3(D1)、去-N-乙酰基溶血-GM3(D2)、溶血-GM3(D3)、含N-乙酰基鞘氨醇的去-N-乙酰基-GM3(D4)和含N-乙酰基鞘氨醇的GM3(D5)。制备D1的关键步骤是使用温和的碱性水解条件,在此条件下唾液酸的N-乙酰基优先水解。为了制备D3,设计了使神经氨酸部分的氨基优先N-乙酰化的条件,即把D2掺入二棕榈酰磷脂酰胆碱(dpPC)脂质体中,其中鞘氨醇部分受到保护,神经氨酸的氨基用乙酸盐和水溶性催化剂1-(3-二甲氨基丙基)-3-乙基碳二亚胺(DEC)进行N-乙酰化。当用乙酸酐和碳酸氢钠处理D2的胶束水溶液时,神经氨酸基和鞘氨醇基残基的氨基均发生N-乙酰化,生成D5。这些衍生物的结构通过1H-核磁共振光谱和质谱进行了验证。